| Drug Name | Kanuma (sebelipase alfa) |
|---|---|
| Drug Class | |
| Risk minimization type |
Healthcare provider guide
|
| Specialty (Theraputic area) | |
| Risk |
Risk of allergic reactions and the development of antibodies against the medicine. |
| Health care provider guide |
|